Kureha Past Earnings Performance
Past criteria checks 0/6
Kureha's earnings have been declining at an average annual rate of -6.7%, while the Chemicals industry saw earnings growing at 9.4% annually. Revenues have been growing at an average rate of 6.1% per year. Kureha's return on equity is 4%, and it has net margins of 5%.
Key information
-6.7%
Earnings growth rate
-5.5%
EPS growth rate
| Chemicals Industry Growth | 6.6% |
| Revenue growth rate | 6.1% |
| Return on equity | 4.0% |
| Net Margin | 5.0% |
| Last Earnings Update | 30 Sep 2024 |
Revenue & Expenses Breakdown
How Kureha makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 171,124 | 8,588 | 32,366 | 0 |
| 30 Jun 24 | 176,148 | 9,367 | 32,830 | 0 |
| 31 Mar 24 | 177,973 | 9,734 | 32,606 | 0 |
| 31 Dec 23 | 175,151 | 9,449 | 32,780 | 0 |
| 30 Sep 23 | 178,012 | 11,475 | 32,650 | 0 |
| 30 Jun 23 | 185,756 | 14,645 | 32,105 | 0 |
| 31 Mar 23 | 191,277 | 16,868 | 31,973 | 0 |
| 31 Dec 22 | 194,210 | 18,501 | 30,762 | 0 |
| 30 Sep 22 | 191,027 | 18,026 | 29,730 | 0 |
| 30 Jun 22 | 179,773 | 16,321 | 28,657 | 0 |
| 31 Mar 22 | 168,341 | 14,164 | 27,521 | 0 |
| 31 Dec 21 | 162,001 | 15,032 | 26,497 | 0 |
| 30 Sep 21 | 157,606 | 17,008 | 26,052 | 0 |
| 30 Jun 21 | 150,958 | 14,747 | 25,888 | 0 |
| 31 Mar 21 | 144,575 | 13,493 | 25,438 | 0 |
| 31 Dec 20 | 142,647 | 4,780 | 26,256 | 0 |
| 30 Sep 20 | 138,858 | 10,175 | 26,854 | 0 |
| 30 Jun 20 | 141,838 | 12,124 | 27,284 | 0 |
| 31 Mar 20 | 142,398 | 13,719 | 28,105 | 0 |
| 31 Dec 19 | 142,890 | 23,541 | 27,960 | 0 |
| 30 Sep 19 | 145,377 | 16,969 | 28,145 | 0 |
| 30 Jun 19 | 145,735 | 15,078 | 28,277 | 0 |
| 31 Mar 19 | 148,265 | 13,933 | 28,051 | 0 |
| 31 Dec 18 | 147,892 | 11,291 | 28,214 | 0 |
| 30 Sep 18 | 150,298 | 9,255 | 27,887 | 0 |
| 30 Jun 18 | 149,441 | 10,595 | 27,494 | 0 |
| 31 Mar 18 | 147,329 | 9,697 | 27,193 | 0 |
| 31 Dec 17 | 149,131 | 9,202 | 26,708 | 0 |
| 30 Sep 17 | 141,563 | 9,712 | 26,520 | 0 |
| 30 Jun 17 | 136,446 | 8,636 | 26,445 | 0 |
| 31 Mar 17 | 132,294 | 7,001 | 26,632 | 0 |
| 31 Dec 16 | 130,533 | 9,832 | 21,995 | 4,830 |
| 30 Sep 16 | 133,914 | 7,038 | 22,144 | 4,830 |
| 30 Jun 16 | 137,967 | 6,366 | 22,571 | 4,830 |
| 31 Mar 16 | 142,549 | 7,342 | 22,850 | 4,830 |
| 31 Dec 15 | 139,443 | 3,810 | 23,396 | 4,842 |
| 30 Sep 15 | 145,596 | 8,169 | 23,472 | 4,842 |
| 30 Jun 15 | 149,143 | 9,417 | 23,251 | 4,842 |
| 31 Mar 15 | 150,182 | 9,195 | 23,074 | 4,842 |
| 31 Dec 14 | 157,566 | 11,280 | 23,468 | 4,528 |
| 30 Sep 14 | 153,850 | 8,243 | 23,153 | 4,528 |
| 30 Jun 14 | 151,241 | 6,566 | 22,944 | 4,528 |
| 31 Mar 14 | 148,124 | 7,365 | 22,659 | 4,528 |
| 31 Dec 13 | 141,032 | 5,371 | 22,175 | 4,389 |
Quality Earnings: 4023 has a large one-off loss of ¥5.3B impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 4023's current net profit margins (5%) are lower than last year (6.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4023's earnings have declined by 6.7% per year over the past 5 years.
Accelerating Growth: 4023's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4023 had negative earnings growth (-25.2%) over the past year, making it difficult to compare to the Chemicals industry average (14%).
Return on Equity
High ROE: 4023's Return on Equity (4%) is considered low.